CHEMBIO DIAGNOSTIC SYSTESMS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A RAPID POINT OF CARE TEST FOR PREECLAMPSIA Chembio Diagnostic System, Inc. (Chembio), a wholly owned…
FOOD AND DRUG ADMINISTRATION AWARDS BREAKTHROUGH DEVICE STATUS TO THE DPP® SYPHILIS TnT ASSAY Medford, N.Y. USA / Strasbourg, France – July 29, 2025 – Chembio Diagnostic Systems, Inc., a…
Medford N.Y USA/Strasbourg France – June 17, 2025 – Chembio Diagnostic Systems, Inc., a subsidiary of Biosynex, developer and manufacturer of rapid diagnostic tests, announced today that the U.S. Food…
Chembio Diagnostics Inc., a subsidiary of Biosynex, receives a grant for Development of a DPP Congenital Syphilis Assay Medford N.Y USA/Strasbourg France , Oct 23, 2024 Chembio Diagnostics, Inc. (Chembio), a…
